Otolaryngologist, head and neck surgeon Francis T. Hall discusses the evaluation of thyroid nodules, which primarily aims to determine the likelihood of malignancy. He then reviews the treatment of thyroid nodules and thyroid cancer, including recent advances in management
Low response to losartan and metformin may be an issue of genetics, not adherence
+Print Archive
Practice
Low response to losartan and metformin may be an issue of genetics, not adherence
Wednesday 17 June 2020, 01:30 AM

Cilazapril/hydrochlorothiazide was recently discontinued, providing an opportunity for blood pressure review in many patients
PHARMACOTHERAPY
Pharmacogenomics is an area that continues to expand, especially for medicines that target specific metabolic pathways or are metabolised by
enzymes that have polymorphisms. This article explores how genetic variation can influence two common medicines
Leanne Te Karu and Linda Bryant
Key points
Losartan may reduce serum urate levels slightly (by 3–10 per cent), but this is not currently predictable.
Losartan is unsuitable a
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.